WO2017184227A3 - Recombinase genome editing - Google Patents

Recombinase genome editing Download PDF

Info

Publication number
WO2017184227A3
WO2017184227A3 PCT/US2017/016184 US2017016184W WO2017184227A3 WO 2017184227 A3 WO2017184227 A3 WO 2017184227A3 US 2017016184 W US2017016184 W US 2017016184W WO 2017184227 A3 WO2017184227 A3 WO 2017184227A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
nucleic acid
single strand
recombinase
genome editing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2017/016184
Other languages
French (fr)
Other versions
WO2017184227A2 (en
Inventor
George M. Church
Christopher J. Gregg
Marc J. Lajoie
Xavier RIOS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Priority to US16/075,281 priority Critical patent/US20210332350A1/en
Publication of WO2017184227A2 publication Critical patent/WO2017184227A2/en
Publication of WO2017184227A3 publication Critical patent/WO2017184227A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A method of altering a target nucleic acid sequence within a cell is provided including providing the cell with a donor nucleic acid, providing the cell with a single strand annealing protein, and providing the cell with a single strand DNA binding protein, wherein one or more or both of the single strand annealing protein and the single strand DNA binding protein is foreign to the cell, and wherein the donor nucleic acid is recombined into the target nucleic acid.
PCT/US2017/016184 2016-02-04 2017-02-02 Recombinase genome editing Ceased WO2017184227A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/075,281 US20210332350A1 (en) 2016-02-04 2017-02-02 Recombinase Genome Editing

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662291499P 2016-02-04 2016-02-04
US62/291,499 2016-02-04
US201662315336P 2016-03-30 2016-03-30
US62/315,336 2016-03-30

Publications (2)

Publication Number Publication Date
WO2017184227A2 WO2017184227A2 (en) 2017-10-26
WO2017184227A3 true WO2017184227A3 (en) 2018-02-08

Family

ID=60116930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/016184 Ceased WO2017184227A2 (en) 2016-02-04 2017-02-02 Recombinase genome editing

Country Status (2)

Country Link
US (1) US20210332350A1 (en)
WO (1) WO2017184227A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11041172B2 (en) 2019-06-25 2021-06-22 Inari Agriculture, Inc. Homology dependent repair genome editing

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111690587B (en) * 2019-03-13 2022-10-25 上海凯赛生物技术股份有限公司 Method for centrifugally screening grease yeast strains with high oil content and application thereof
WO2020237066A2 (en) * 2019-05-23 2020-11-26 President And Fellows Of Harvard College Gene editing in diverse bacteria
WO2021233975A1 (en) 2020-05-20 2021-11-25 Commissariat à l'Energie Atomique et aux Energies Alternatives In-cell continuous target-gene evolution, screening and selection
CN112194514A (en) * 2020-10-12 2021-01-08 齐齐哈尔量子生物科技有限公司 Bio-organic fertilizer starter and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144734B2 (en) * 2000-08-14 2006-12-05 The United States Of America As Represented By The Department Of Health And Human Services Enhanced homologous recombination mediated by lambda recombination proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144734B2 (en) * 2000-08-14 2006-12-05 The United States Of America As Represented By The Department Of Health And Human Services Enhanced homologous recombination mediated by lambda recombination proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANTONY ET AL.: "Multiple C-terminal tails within a single E. coli SSB homotetramer coordinate DNA replication and repair", J MOL BIO, vol. 425, no. 23, 2013, pages 4802 - 4819, XP028766573 *
DATABASE GenBank [O] 2 April 2015 (2015-04-02), "single-stranded DNA-binding protein [Escherichia coli K-12]", XP055462012, Database accession no. CQR83440.1. *
DATABASE GenBank [O] 26 November 2012 (2012-11-26), "hypothetical protein PA39016_003090055 [Pseudomonas aeruginosa 39016]", XP055462020, Database accession no. ZP 07797103.1 *
DATABASE GenBank 8 February 2016 (2016-02-08), "phage recombination protein Bet [Pseudomonas aeruginosa]", XP055462028, Database accession no. WP_003088368.1 *
MEYER ET AL.: "The single-stranded DNA-binding protein of Escherichia coli", MICROBIOL REV, vol. 54, no. 4, 1990, pages 342 - 380, XP055462010 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11041172B2 (en) 2019-06-25 2021-06-22 Inari Agriculture, Inc. Homology dependent repair genome editing

Also Published As

Publication number Publication date
US20210332350A1 (en) 2021-10-28
WO2017184227A2 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
WO2016046778A3 (en) Protease-activatable bispecific proteins
WO2014205192A3 (en) Targeted integration
WO2016033315A3 (en) Synthon formation
WO2018191715A3 (en) Polypeptides with type v crispr activity and uses thereof
WO2017070633A3 (en) Evolved cas9 proteins for gene editing
WO2016057951A3 (en) Crispr oligonucleotides and gene editing
WO2017184227A3 (en) Recombinase genome editing
EP3392337A4 (en) Genetic modification non-human organism, egg cells, fertilized eggs, and method for modifying target genes
MX2018001617A (en) Engineered crispr-cas9 compositions and methods of use.
EP3942066A4 (en) Nucleic acid hybridization methods
SA523441205B1 (en) Multiplex genome editing
EP3910067A4 (en) Nucleic acid release agent, nucleic acid pcr amplification method and pcr amplification kit
WO2015196128A3 (en) Alternative nucleic acid molecules and uses thereof
WO2015196130A3 (en) Alternative nucleic acid molecules and uses thereof
EP3303607A4 (en) Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
EP3699280A3 (en) Novel cas9 systems and methods of use
WO2015170323A3 (en) Compositions and methods of using same for reducing resistance to mosquito larvicides
WO2016012544A3 (en) Enhanced reprogramming to ips cells
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
CA3010891A1 (en) Recombinogenic nucleic acid strands in situ
WO2014039692A3 (en) Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
WO2018053365A8 (en) Methods of nucleic acid sample preparation for analysis of cell-free dna
WO2016130704A3 (en) Methods and compositions for analyzing cellular components
WO2017044857A3 (en) Methods and compositions for the treatment of glaucoma
WO2014197568A3 (en) Rna-guideded transcriptional regulation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17786273

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17786273

Country of ref document: EP

Kind code of ref document: A2